Geode Capital Management
ROIV icon

Geode Capital Management’s Roivant Sciences ROIV Stock Holding History

Geode Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$468M Buy
12,521,620
+847,240
+7% +$30.7M 0.02% 472
2026
Q2 		$426M Buy
11,674,380
+1,491,903
+15% +$44.1M 0.02% 511
2026
Q1 		$282M Buy
10,182,477
+2,028,931
+25% +$52.1M 0.02% 608
2025
Q4 		$177M Sell
8,153,546
-49,048
-0.6% -$968K 0.01% 766
2025
Q3 		$124M Buy
8,202,594
+452,195
+6% +$5.6M 0.01% 940
2025
Q2 		$87.4M Sell
7,750,399
-216,986
-3% -$2.35M 0.01% 1105
2025
Q1 		$80.4M Buy
7,967,385
+195,554
+3% +$2.11M 0.01% 1102
2024
Q4 		$92M Buy
7,771,831
+26,727
+0.3% +$316K 0.01% 1063
2024
Q3 		$89.4M Buy
7,745,104
+1,460,205
+23% +$16.6M 0.01% 1065
2024
Q2 		$66.4M Buy
6,284,899
+238,053
+4% +$2.61M 0.01% 1167
2024
Q1 		$63.7M Buy
6,046,846
+522,270
+9% +$5.63M 0.01% 1186
2023
Q4 		$62.1M Buy
5,524,576
+306,396
+6% +$2.99M 0.01% 1202
2023
Q3 		$61M Buy
5,218,180
+2,478,175
+90% +$28M 0.01% 1097
2023
Q2 		$27.6M Buy
2,740,005
+1,118,562
+69% +$10M ﹤0.01% 1643
2023
Q1 		$12M Buy
1,621,443
+95,750
+6% +$788K ﹤0.01% 2139
2022
Q4 		$12.2M Buy
1,525,693
+81,607
+6% +$454K ﹤0.01% 2123
2022
Q3 		$4.65M Buy
1,444,086
+59,614
+4% +$231K ﹤0.01% 2720
2022
Q2 		$5.63M Buy
1,384,472
+94,293
+7% +$374K ﹤0.01% 2638
2022
Q1 		$6.37M Buy
1,290,179
+130,042
+11% +$858K ﹤0.01% 2648
2021
Q4 		$11.7M Buy
+1,160,137
New +$9.7M ﹤0.01% 2344

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Patient Square Capital
Patient Square Capital Menlo Park, California $627M AUM 115.4% 1-Year Est. Return

Geode Capital Management's ROIV Position: Q3 2026 in Review

Geode Capital Management increased its Roivant Sciences (ROIV) stake by 7.3% in Q3 2026, buying an estimated $30.7M and bringing the position to 12,521,620 shares worth $468M. The position accounts for 0.02% of the portfolio, ranked #472.

Geode Capital Management first reported a position in ROIV in Q4 2021 and has held it in 20 quarters since. 395 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Geode Capital Management held 12,521,620 shares of Roivant Sciences worth $468M as of Q3 2026.
  • Geode Capital Management bought 847,240 Roivant Sciences shares in Q3 2026, an estimated $30.7M.
  • Roivant Sciences made up 0.02% of Geode Capital Management's portfolio in Q3 2026, its #472 holding.
  • Geode Capital Management first reported a position in Roivant Sciences in Q4 2021 and has held it in 20 quarters since.
  • 395 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.